Prostate cancer in Asia: A collaborative report

作者：Rui Chen, Shancheng Ren, Ming Kwong Yiu, Ng Chi Fai, W. S. Cheng, Lap Hong Ian, Seiji Naito, Tadashi Matsuda, Elijah O. Kehinde, Ali Rıza Kural, Jason Yichun Chiu, Rainy Umbas, Qiang Wei, Xiaolei Shi, Liqun Zhou, Jian Huang, Yong Huang, Liping Xie, Lulin Ma, Changjun Yin, Danfeng Xu, Kexin Xu, Zhangqun Ye, Chunxiao Liu, Dingwei Ye, Xin Gao, Qiang Fu, Jianquan Hou, Jianlin Yuan, Dalin He, Tiejun Pan, Qiang Ding, Fengshuo Jin, Benkang Shi, Gongxian Wang, Xiuheng Liu, Dongwen Wang, Zhoujun Shen, Xiangbo Kong, Wanhai Xu, Yaoliang Deng, Haibo Xia, Alexa Cohen, Xu Gao, Chuanliang Xu, Yinghao Sun · 发表于：Asian journal of urology · 年份：2014 · DOI：10.1016/j.ajur.2014.08.007 · 被引用次数：210 · 研究领域：Prostate Cancer Diagnosis and Treatment、Prostate Cancer Treatment and Research、Bladder and Urothelial Cancer Treatments

The incidence of prostate cancer (PCa) within Asian population used to be much lower than in the Western population; however, in recent years the incidence and mortality rate of PCa in some Asian countries have grown rapidly. This collaborative report summarized the latest epidemiology information, risk factors, and racial differences in PCa diagnosis, current status and new trends in surgery management and novel agents for castration-resistant prostate cancer. We believe such information would be helpful in clinical decision making for urologists and oncologists, health-care ministries and medical researchers.